Lulyera XL 1% Cream contains Luliconazole 1% w/w, a topical antifungal agent belonging to the imidazole class. It is indicated for the treatment of superficial fungal infections of the skin caused by dermatophytes, yeasts, and other susceptible fungi, including tinea corporis, tinea cruris, tinea pedis, and candidiasis. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation allows for targeted delivery of the active ingredient to the affected skin areas, promoting rapid relief of symptoms such as itching, redness, and inflammation. Lulyera XL 1% Cream is typically applied once daily to the clean, dry affected area and surrounding skin for a duration recommended by a healthcare professional, usually ranging from one to two weeks depending on the infection severity. It is generally well tolerated, with adverse effects being rare and mild, including localized irritation or burning sensation. Patients should avoid contact with eyes and mucous membranes and discontinue use if hypersensitivity reactions occur. Lulyera XL 1% Cream offers an effective and convenient option for managing superficial fungal infections, improving patient compliance through its once-daily application regimen.